ulinastatin injection
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
350
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
September 24, 2026
CURE-SepSIRS: Clinical Efficacy of Ulinastatin for Treatment of Sepsis With Systemic Inflammatory Response Syndrome
(clinicaltrials.gov)
- P3 | N=120 | Completed | Sponsor: Huashan Hospital | Not yet recruiting ➔ Completed
Trial completion • Immunology • Infectious Disease • Inflammation • Septic Shock • Systemic Inflammatory Response Syndrome
September 24, 2026
Genome-wide exploration of coat color-associated loci in Hokkaido Native Horses, with a novel locus implicated in the roan phenotype.
(PubMed, J Equine Sci)
- "Among genes with known functions, PIK3C3, which is involved in autophagy, a process associated with melanosome degradation and pigment lightening, was the closest to the chromosome 8 signal. At the chromosome 3 lead SNP, all horses with the GG genotype were roan, but roan and non-roan horses were mixed in the other genotype classes at this SNP and in the genotype classes at the chromosome 8 lead SNP, indicating that genotype-based identification of roan horses is possible only for a subset of animals."
Journal • PIK3C3
September 23, 2026
Efficacy and safety of Xuebijing combined with ulinastatin in the treatment of sepsis complicated by acute lung injury: a meta-analysis.
(PubMed, Am J Transl Res)
- "Xuebijing combined with ulinastatin may reduce inflammation, improve lung function and disease severity, shorten mechanical ventilation duration and increase response and survival rates without increasing adverse events. Owing to heterogeneity in treatment regimens and inclusion criteria, these findings require validation in large-scale, multicenter RCTs."
Journal • Retrospective data • Review • Acute Lung Injury • Infectious Disease • Inflammation • Respiratory Diseases • Septic Shock • CRP • IL6 • TNFA
July 15, 2026
NON-LINEAR J-SHAPED DOSE-RESPONSE RELATIONSHIP BETWEEN ULINASTATIN DOSE AND MORTALITY IN ACUTE PANCREATITIS: A RETROSPECTIVE PROPENSITY SCORE-MATCHED COHORT STUDY
(UEGW 2026)
- No abstract available
Retrospective data • Pancreatitis
August 24, 2026
Preventive effect of ulinastatin on postoperative cognitive dysfunction through modulation of the gut microbiome: evidence from short-chain fatty acids.
(PubMed, Brain Behav Immun Health)
- "Ulinastatin (50,000 U/mL) or normal saline (1 mL) was intraperitoneally administered before general anaesthesia, which was maintained with isoflurane 1.5 vol% for 2 h. Preoperative administration of ulinastatin prevented cognitive decline after general anaesthesia. The protective effect of ulinastatin was associated with control of gut dysbiosis."
Journal • Anesthesia • Cognitive Disorders • NFE2L2
August 09, 2026
Treatment protocol for pneumonia with acute kidney injury: effects of ulinastatin combined with CRRT on inflammatory factors and renal function in patients.
(PubMed, Front Med (Lausanne))
- "The combination of ulinastatin and CRRT may offer additional benefits over CRRT alone in improving clinical symptoms, inflammatory markers, renal function, and pulmonary function in patients with pneumonia complicated by AKI. However, given the retrospective nature of this study, these findings should be considered preliminary and require confirmation in large-scale, prospective, randomized controlled trials."
Journal • Acute Kidney Injury • Infectious Disease • Nephrology • Oncology • Pneumonia • Renal Disease • Respiratory Diseases • CRP • CST3 • CXCL8 • IL6 • TNFA
August 07, 2026
A Rare Case of Kawasaki Disease Complicating Poststreptococcal Acute Glomerulonephritis.
(PubMed, Pediatr Int)
- No abstract available
Journal • Glomerulonephritis • Lupus Nephritis • Nephrology • Renal Disease
August 06, 2026
Effects of meropenem plus ulinastatin on inflammatory response and complications in patients with severe septic shock.
(PubMed, Front Med (Lausanne))
- "In this single-center retrospective cohort, receipt of ulinastatin in addition to meropenem-based standard care was associated with more favorable inflammatory, coagulation, lactate-clearance, hemodynamic, immune, and resource-use outcomes. Because treatment was not randomized and residual confounding cannot be excluded, these findings should not be interpreted as proof of causality or synergy."
Journal • Inflammation • Septic Shock • CD4 • CD8 • CXCL8 • IL6 • TNFA
July 28, 2026
A dual-mode electrochemiluminescence/fluorescence biosensor based on CeO2:Eu3+-Au@Au nanomaterials for highly sensitive detection of ulinastatin.
(PubMed, Anal Chim Acta)
- "The FL sensor exhibited good linearity for UTI with a LOD of 0.026 nM in the linear range of 10-10 - 10-4 M. When this dual-mode biosensor was applied to the detection of UTI in serum samples, the results of both detection modes were satisfactory."
Journal • ELANE
July 23, 2026
Efficacy of early high-dose Ulinastatin pulse therapy for HTGP: A single-center randomized controlled trial
(ChiCTR)
- P=N/A | N=66 | Not yet recruiting | Sponsor: The First Affiliated Hospital of Nanchang University; The First Affiliated Hospital of Nanchang University
New trial • Pancreatitis • CXCL8
July 16, 2026
Association of ulinastatin with 28-day mortality across different severities of viral pneumonia: a multicenter propensity score-matched study.
(PubMed, Front Pharmacol)
- "Further studies are needed to confirm these findings across specific viral etiologies. These hypothesis-generating findings highlight the need for precision immunomodulation targeting the optimal therapeutic window."
Journal • Critical care • Immunology • Infectious Disease • Inflammation • Influenza • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases
July 16, 2026
Morphostructural, Phaneroptic Characterization, and Zoometric Indices of Creole Cattle (Bos taurus) from the High Andean Region of Ayacucho, Peru.
(PubMed, Animals (Basel))
- "The proportions of red, black, dull black, qosca, and roan coat colors were common across all biotypes; however, Biotype 1 predominated in callejón (15.38%), Biotype 2 in qosne (8.11%) and in other less frequent coat colors (10.81%), while Biotype 3 predominated in dark roan (16.67%) and jet black (11.11%). In the high-Andean region of Ayacucho, three subpopulations of Creole cattle were identified with potential for beef production, dual-purpose use, and adaptation to rugged terrain, highlighting the need to investigate their genetic diversity."
Journal
July 09, 2026
Effect of Ulinastatin on the Action of NDMRs (Rocuronium / Cisatracurium)
(clinicaltrials.gov)
- P=N/A | N=120 | Completed | Sponsor: Huazhong University of Science and Technology | Not yet recruiting ➔ Completed | N=80 ➔ 120
Enrollment change • Trial completion
July 01, 2026
Ulinastatin Treatment Associated with Lower Sepsis-Associated Encephalopathy Risk in Sepsis Patients: A Multicenter Observational Study.
(PubMed, Shock)
- "Ulinastatin treatment is significantly associated with reduced SAE incidence in sepsis patients, offering novel insights and potential therapeutic strategies for preventing SAE and improving neurological outcomes."
Biomarker • Journal • Observational data • Retrospective data • CNS Disorders • Infectious Disease • Septic Shock
June 30, 2026
Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal Infection
(clinicaltrials.gov)
- P=N/A | N=165 | Not yet recruiting | Sponsor: Fujian Medical University Union Hospital
New trial • Immunology • Infectious Disease • Inflammation • Septic Shock • Systemic Inflammatory Response Syndrome
June 23, 2026
The interplay between type 2 diabetes mellitus and sepsis: a scoping review.
(PubMed, Int J Med Sci)
- "Metformin, sodium-glucose co-transporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors, and statins exhibited immunomodulatory effects. Granulocyte-macrophage colony-stimulating factor and ulinastatin restored immune function and suppressed inflammation. Larger multi-ethnic studies are warranted to define optimal glycaemic targets, uncover immune-metabolic interactions, identify biomarkers, and optimise T2DM management in sepsis."
Journal • Review • Diabetes • Immunology • Infectious Disease • Inflammation • Metabolic Disorders • Septic Shock • Type 2 Diabetes Mellitus • CCL2
June 13, 2026
First Report of Mycobacterium bovis and Nocardia spp. Co-Infection in a Roan Antelope.
(PubMed, Animals (Basel))
- "Mixed infections in captive wildlife represent a One Health concern, as the potential for zoonotic adaptation and transmission to humans cannot be excluded. Therefore, pathogen surveillance is of particular importance within zoological collections."
Journal • Cardiovascular • Infectious Disease • Pneumonia • Pulmonary Disease • Respiratory Diseases
June 02, 2026
Effects of Ulinastatin and Tranexamic Acid in Cardiac Surgery: A Systematic Review and Meta-Analysis.
(PubMed, J Coll Physicians Surg Pak)
- "Therefore, the combination of ULI and TXA exhibits a synergistic effect on haemostasis and preservation of coagulation function, representing an optimised strategy for blood management in cardiac surgery. Key Words: Ulinastatin, Tranexamic acid, Cardiac surgery, Bleeding, Transfusion."
Clinical • Journal • Retrospective data • Review • Cardiovascular
May 29, 2026
Comparative efficacy and safety of immunomodulatory therapies for sepsis: a systematic review and network meta-analysis.
(PubMed, Front Med (Lausanne))
- "On the basis of the findings of this first network meta-analysis evaluating a broad spectrum of immunomodulators for sepsis, ulinastatin (alone or in combination with thymosin-α1), PUFA, and MAb have significant potential for reducing mortality and improving other clinical outcomes. However, the certainty of evidence for most comparisons remains low, which underscores the need for large-scale, direct-comparison RCTs to validate these findings and guide clinical practice."
Journal • Retrospective data • Review • Critical care • Infectious Disease • Septic Shock
May 23, 2026
The impact of ulinastatin on postoperative clinical outcomes in patients with gastric cancer: a retrospective cohort analysis.
(PubMed, J Gastrointest Oncol)
- "Intraoperative UTI attenuates postoperative CRP and ALT elevation, reflecting anti-inflammatory and partial hepatoprotective effects. Integration of UTI into comprehensive perioperative management may enhance clinical recovery."
Clinical data • Journal • Retrospective data • Diabetes • Gastric Adenocarcinoma • Gastric Cancer • Metabolic Disorders • Oncology • Solid Tumor • CRP
May 21, 2026
Assessment of the Role of Fire Regime as a Determinant of Habitat Selection by Medium-Sized Grazers in a West African Savanna.
(PubMed, Ecol Evol)
- "We used total aerial counts of great mammals in the Pendjari Biosphere Reserve and extracted five grazer species data (hartebeest, kob, waterbuck, korrigum, and roan)...Our study provides valuable insights into how grazer species respond to fire regimes and habitat characteristics, shedding light on the complex interplay between these factors. These results can be used to better design a fire management plan in West African savannas which integrate habitat requirements for herbivores."
Journal
May 14, 2026
AURORA: Artificial Intelligence for Ulinastatin Responder Outcome & Risk Assessment in CPB
(clinicaltrials.gov)
- P=N/A | N=10000 | Active, not recruiting | Sponsor: Beijing Anzhen Hospital
New trial • Real-world evidence • Cardiovascular • Immunology • Inflammation • Systemic Inflammatory Response Syndrome
April 30, 2026
A Novel Therapeutic Strategy for Sepsis: The Multiorgan Protective Properties and Clinical Potential of Ulineastatin.
(PubMed, Shock)
- "Ulinastatin (UTI), a serine protease inhibitor with anti-inflammatory and antioxidative properties, has emerged as a promising therapeutic candidate for sepsis-induced organ injury...Clinical and preclinical evidence demonstrates UTI's efficacy in alleviating injury in critical organs, including lungs, heart, liver, spleen, intestines, and kidneys. The current review clarifies the mechanism by which UTI mitigates sepsis-related multiple organ dysfunction syndrome and provides a theoretical basis for identifying potential therapeutic targets of UTI to mitigate sepsis injury."
Journal • Review • Immunology • Infectious Disease • Inflammation • Septic Shock • Systemic Inflammatory Response Syndrome
April 29, 2026
Ulinastatin attenuates capillary leakage and suppresses FoxO1-dependent angiopoietin-2 in sepsis-associated acute lung injury via PI3K pathway.
(PubMed, PLoS One)
- "UTI treatment reduced the expression of angiopoietin-2 (Ang-2), a key mediator of vascular destabilization, and exerted similar protective effects on endothelial function as dexamethasone (DEX). The protective effects of UTI on capillary leakage and junctional protein integrity were abolished by the PI3K inhibitor wortmannin. In conclusion, our findings demonstrate that UTI alleviates SALI by disrupting an Ang-2-mediated vicious cycle via the PI3K/Akt/FoxO1 pathway, revealing a novel mechanistic insight into its therapeutic action against sepsis-induced vascular leakage."
Journal • Acute Lung Injury • Infectious Disease • Respiratory Diseases • Septic Shock
April 24, 2026
Dynamic inflammatory trajectories and 28-day mortality in patients in the intensive care unit: An exploratory observational study.
(PubMed, J Intensive Med)
- "3 patients (P=0.031), whereas vasopressors and ulinastatin showed no trajectory-specific benefits...3) conferring the highest risk. Dynamic biomarker profiling may facilitate the development of targeted immunomodulatory strategies in high-risk subgroups."
Journal • Observational data • Critical care • Inflammation • CRP • IL10 • IL4 • IL6
1 to 25
Of
350
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14